Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of respiratory diseases
3.2.1.2 Growing government approvals and funding
3.2.1.3 Expanding elderly demographic
3.2.1.4 Growing advancement in the drug delivery system
3.2.2 Industry pitfalls & challenges
3.2.2.1 Availability of alternative therapeutic options
3.2.2.2 Side effects and safety concerns
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Dosage Form, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Injection
5.3 Tablet
5.4 Solution
Chapter 6 Market Estimates and Forecast, By Medication Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Generics
6.3 Branded
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Asthma
7.3 Emphysema
7.4 Chronic obstructive pulmonary disease (COPD)
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AdvaCare Pharma
10.2 Amneal Pharmaceuticals LLC
10.3 AstraZeneca AB
10.4 Cipla
10.5 Cooper S.A.
10.6 GSK plc
10.7 Glenmark Pharmaceuticals Ltd.
10.8 Inopha International Co, Limited
10.9 Johnson & Johnson Pvt. Ltd.
10.10 Lupin
10.11 Pfizer Inc.
10.12 S.A.L.F. S.p.A. Laboratorio Farmacologico
10.13 Teva Pharmaceuticals Industries Ltd.
